Mechanosensitive TRPV4 is required for crystal-induced inflammation. Issue 12 (18th October 2021)
- Record Type:
- Journal Article
- Title:
- Mechanosensitive TRPV4 is required for crystal-induced inflammation. Issue 12 (18th October 2021)
- Main Title:
- Mechanosensitive TRPV4 is required for crystal-induced inflammation
- Authors:
- Lan, Zhou
Chen, Lvyi
Feng, Jing
Xie, Zili
Liu, Zhiyong
Wang, Fang
Liu, Peng
Yue, Xueping
Du, Lixia
Zhao, Yonghui
Yang, Pu
Luo, Jialie
Zhu, Zhe
Hu, Xueming
Cao, Liang
Lu, Ping
Sah, Rajan
Lavine, Kory
Kim, Brian
Hu, Hongzhen - Abstract:
- Abstract : Crystal structures activate innate immune cells, especially macrophages and initiate inflammatory responses. We aimed to understand the role of the mechanosensitive TRPV4 channel in crystal-induced inflammation. Real-time RT-PCR, RNAscope in situ hybridisation, and Trpv4 eGFP mice were used to examine TRPV4 expression and whole-cell patch-clamp recording and live-cell Ca 2+ imaging were used to study TRPV4 function in mouse synovial macrophages and human peripheral blood mononuclear cells (PBMCs). Both genetic deletion and pharmacological inhibition approaches were used to investigate the role of TRPV4 in NLRP3 inflammasome activation induced by diverse crystals in vitro and in mouse models of crystal-induced pain and inflammation in vivo. TRPV4 was functionally expressed by synovial macrophages and human PBMCs and TRPV4 expression was upregulated by stimulation with monosodium urate (MSU) crystals and in human PBMCs from patients with acute gout flares. MSU crystal-induced gouty arthritis were significantly reduced by either genetic ablation or pharmacological inhibition of TRPV4 function. Mechanistically, TRPV4 mediated the activation of NLRP3 inflammasome by diverse crystalline materials but not non-crystalline NLRP3 inflammasome activators, driving the production of inflammatory cytokine interleukin-1β which elicited TRPV4-dependent inflammatory responses in vivo. Moreover, chemical ablation of the TRPV1-expressing nociceptors significantly attenuated the MSUAbstract : Crystal structures activate innate immune cells, especially macrophages and initiate inflammatory responses. We aimed to understand the role of the mechanosensitive TRPV4 channel in crystal-induced inflammation. Real-time RT-PCR, RNAscope in situ hybridisation, and Trpv4 eGFP mice were used to examine TRPV4 expression and whole-cell patch-clamp recording and live-cell Ca 2+ imaging were used to study TRPV4 function in mouse synovial macrophages and human peripheral blood mononuclear cells (PBMCs). Both genetic deletion and pharmacological inhibition approaches were used to investigate the role of TRPV4 in NLRP3 inflammasome activation induced by diverse crystals in vitro and in mouse models of crystal-induced pain and inflammation in vivo. TRPV4 was functionally expressed by synovial macrophages and human PBMCs and TRPV4 expression was upregulated by stimulation with monosodium urate (MSU) crystals and in human PBMCs from patients with acute gout flares. MSU crystal-induced gouty arthritis were significantly reduced by either genetic ablation or pharmacological inhibition of TRPV4 function. Mechanistically, TRPV4 mediated the activation of NLRP3 inflammasome by diverse crystalline materials but not non-crystalline NLRP3 inflammasome activators, driving the production of inflammatory cytokine interleukin-1β which elicited TRPV4-dependent inflammatory responses in vivo. Moreover, chemical ablation of the TRPV1-expressing nociceptors significantly attenuated the MSU crystal-induced gouty arthritis. In conclusion, TRPV4 is a common mediator of inflammatory responses induced by diverse crystals through NLRP3 inflammasome activation in macrophages. TRPV4-expressing resident macrophages are critically involved in MSU crystal-induced gouty arthritis. A neuroimmune interaction between the TRPV1-expressing nociceptors and the TRPV4-expressing synovial macrophages contributes to the generation of acute gout flares. … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 80:Issue 12(2021)
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 80:Issue 12(2021)
- Issue Display:
- Volume 80, Issue 12 (2021)
- Year:
- 2021
- Volume:
- 80
- Issue:
- 12
- Issue Sort Value:
- 2021-0080-0012-0000
- Page Start:
- 1604
- Page End:
- 1614
- Publication Date:
- 2021-10-18
- Subjects:
- arthritis -- experimental -- cytokines -- gout -- immune system diseases
Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2021-220295 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26340.xml